Kharituwe TB Contact Tracing Study

NCT ID: NCT04520113

Last Updated: 2025-04-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10579 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to characterize the role of human mobility in fueling TB epidemics and estimate the potential impact of innovative case finding interventions tailored to mobile populations

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators propose a randomized trial of two novel TB case-finding interventions among household members of patients diagnosed with active TB: holiday-based screening in a rural South African province (Limpopo) and off-peak (weekend/evening) screening in an urban settlement into which many residents of Limpopo migrate for work. The investigators will enroll index cases of TB plus their household contacts in each setting and randomize them to novel versus standard contact investigation. In Specific Aim 1, investigators will use whole genome sequencing of all cases, overlaying transmission trees with data on human movement, to evaluate associations between mobility and TB transmission in this population. In Specific Aim 2, investigators will employ a multidisciplinary approach to compare novel versus standard contact investigation in each setting along the following dimensions: (a) effectiveness (number of secondary TB cases diagnosed and starting treatment); (b) implementation (reach, fidelity, and maintenance of contact investigation outside of business hours); (c) cost-effectiveness (cost per disability-adjusted life year) and budget impact; and (d) projected population-level impact on TB incidence. Successful completion of these aims will have long-term impact by characterizing the role of mobility in fueling TB epidemics and testing two tailored approaches to improve TB control in highly mobile populations - an underserved group that is increasingly recognized as playing a major role in global TB transmission.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis Hiv

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Investigators
The principal investigators are blinded as to the assignment of treatment to participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Tracing

Households of tuberculosis index patients receive "standard" household contact tracing during regular weekday business hours.

Group Type ACTIVE_COMPARATOR

Household contact tracing

Intervention Type BEHAVIORAL

Household contact tracing to test and diagnose Tuberculosis of household contacts of Tuberculosis patients.

Holiday Tracing

Households of tuberculosis index patients in rural South Africa receive household contact tracing during holidays (Christmas and Easter).

Group Type EXPERIMENTAL

Household contact tracing

Intervention Type BEHAVIORAL

Household contact tracing to test and diagnose Tuberculosis of household contacts of Tuberculosis patients.

Evening / Weekend Tracing

Households of tuberculosis index patients in urban South Africa receive household contact tracing during evenings and weekends.

Group Type EXPERIMENTAL

Household contact tracing

Intervention Type BEHAVIORAL

Household contact tracing to test and diagnose Tuberculosis of household contacts of Tuberculosis patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Household contact tracing

Household contact tracing to test and diagnose Tuberculosis of household contacts of Tuberculosis patients.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 0-99 years (Including those recently deceased)
* Diagnosed with pulmonary TB at a study hospital or clinic (microbiological and/or chest x-ray diagnosis)


* Age 0-99 years
* Currently resides with or visiting eligible TB index case

Exclusion Criteria

* Unwilling/unable to provide informed consent (including next of kin, for those recently deceased)
* Plan not to pursue TB treatment within the study district
* Unwilling/unable to comply with study procedures

Contacts:


* Unwilling/unable to provide informed consent
* Unwilling/unable to comply with study procedures
Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Perinatal HIV Research Unit of the University of the Witswatersrand

OTHER

Sponsor Role collaborator

Setshaba Research Centre

UNKNOWN

Sponsor Role collaborator

The National Institute for Communicable Diseases

UNKNOWN

Sponsor Role collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David W. Dowdy, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins Bloomberg School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Perinatal HIV Research Unit (PHRU)

Johannesburg, , South Africa

Site Status

Setshaba Research Centre

Soshanguve, , South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Africa

References

Explore related publications, articles, or registry entries linked to this study.

Young N, Biche P, Mohlamonyane M, Morolo M, Maholwana B, Ahmed K, Martinson N, Hanrahan CF, Dowdy DW. Innovative timing strategies for tuberculosis household contact investigation: cost-effectiveness analysis from a randomized trial in rural and urban South Africa (Kharituwe Study). EClinicalMedicine. 2025 May 26;84:103259. doi: 10.1016/j.eclinm.2025.103259. eCollection 2025 Jun.

Reference Type DERIVED
PMID: 40503514 (View on PubMed)

Mlambo LM, Milovanovic M, Hanrahan CF, Motsomi KW, Morolo MT, Mohlamonyane MP, Albaugh NW, Ahmed K, Martinson NA, Dowdy DW, West NS. The impact of ethical implications intertwined with tuberculosis household contact investigation: a qualitative study. medRxiv [Preprint]. 2024 Jun 28:2024.06.27.24309538. doi: 10.1101/2024.06.27.24309538.

Reference Type DERIVED
PMID: 38978659 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00011124

Identifier Type: OTHER

Identifier Source: secondary_id

R01AI147681

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Host Blood RNA Signatures for Diagnosis of TB
NCT05542511 ACTIVE_NOT_RECRUITING
The Correlate of Risk Targeted Intervention Study
NCT02735590 UNKNOWN PHASE2/PHASE3
Infant TB Infection Prevention Study
NCT02613169 COMPLETED PHASE2